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Abstract
Background: Primary care physicians and other primary health care professionals from Alberta, Canada identified a
clinical pathway as a potential tool to facilitate uptake of clinical practice guidelines for the diagnosis, management
and referral of adults with chronic kidney disease. We describe the development and implementation of a chronic
kidney disease clinical pathway (CKD-CP; www.ckdpathway.ca).
Methods: The CKD-CP was developed and implemented based on the principles of the Knowledge-To-Action
Cycle framework. We used a mixed methods approach to identify the usability and feasibility of the CKD-CP. This
included individual interviews, an online survey and website analytics, to gather data on barriers and facilitators to
use, perceived usefulness and characteristics of users. Results are reported using conventional qualitative content
analysis and descriptive statistics.
Results: Eighteen individual interviews were conducted with primary care physicians, nephrologists, pharmacists
and nurse practitioners to identify themes reflecting both barriers and facilitators to integrating the CKD-CP into
clinical practice. Themes identified included: communication, work efficiency and confidence. Of the 159
participants that completed the online survey, the majority (52 %) were first time CKD-CP users. Among those who
had previously used the CKD-CP, 94 % agreed or strongly agreed that the pathway was user friendly, provided
useful information and increased their knowledge and confidence in the care of patients with CKD. Between
November 2014 and July 2015, the CKD-CP website had 10,710 visits, 67 % of which were new visitors. The 3 most
frequently visited web pages were home, diagnose and medical management. Canada, Indonesia and the United
States were the top 3 countries accessing the website during the 9 month period.
Conclusions: An interactive, online, point-of-care tool for primary care providers can be developed and
implemented to assist in the care of patients with CKD. Our findings are important for making refinements to the
CKD –CP website via ongoing discussions with end-users and the development team, along with continued
dissemination using multiple strategies.
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Background
Chronic kidney disease (CKD; defined by estimated
glomerular filtration rate [eGFR] < 60 ml/min/1.73 m2)
affects 12.5 % of adults in Canada [1]. Identification and
management of CKD is complex. In 2012, the Kidney
Disease Improving Global Outcomes (KDIGO) Clinical
Practice Guidelines for CKD were published with an aim
to provide clinical practitioners with guidance for the
care of patients with CKD [2]. Primary care physicians
play a key role in identification, management and ref-
erral of patients with CKD, caring for approximately
95 % of patients with CKD [3]. Therefore, they are an
important group upon which to focus activities aimed at
dissemination and uptake of CKD guidelines. Clinical
practice guidelines are intended to address evidence-
practice gaps, however translating evidence into primary
care can be challenging – up to 50 % of elderly patients
with CKD in Alberta were not taking medications
indicated to reduce cardiovascular risk and only 20 % of
patients who meet referral criteria were seen by a kidney
specialist [3]. Understanding this key gap, we sought the
optimal knowledge translation (KT) intervention that
would increase the uptake of guideline-concordant CKD
care in clinical practice [4, 5].
We used the Knowledge-To-Action Cycle framework,
which provides a structured approach to identifying,
implementing and evaluating the uptake of evidence into
practice [6]. This framework includes 7 phases: (1) identify
the problem; (2) adapt knowledge to local context; (3)
assess barriers and facilitators to knowledge use; (4) select,
tailor and implement interventions; (5) monitor knowledge
use; (6) evaluate outcomes; and (7) sustain knowledge use
([6], p.11). We used this framework to address the
evidence-practice gap for CKD care (i.e. diagnosis, manage-
ment and referral) in the primary care setting.
In the first three phases of this work (details of which
are reported elsewhere [4]), focus groups with primary
care providers and surveys of patients with CKD were
followed by a stakeholder meeting with primary care
physicians, nephrologists, laboratory medicine, KT special-
ists, researchers, patients and decision-makers. At the
stakeholder meeting, the Cochrane Effective Practice and
Organization of Care taxonomy framework [4] was used
to ensure all relevant KT interventions were considered.
At the end of this process a clinical pathway was identified
as the preferred approach to facilitate CKD care in the
primary care setting. In contrast to clinical practice
guidelines, a clinical pathway is explicit about the timing,
sequence and provision of interventions [7].
Given the lack of a unified definition of a “clinical
pathway” [8], we considered a clinical pathway to be a
“methodology for the mutual decision making and
organization of care for a well-defined group of patients
during a well-defined period” [9]. Clinical pathways have
been shown to improve the quality, consistency and
continuity of care, and enhance evidence-based and
patient-focused care [10, 11]. They have also been identi-
fied by the Strategic Clinical Networks (networks of clini-
cians and patients with knowledge about a specific health
area) at Alberta Health Services as a preferred strategy to
improve the quality of care provided to Albertans [12].
We completed a scoping review to determine the avail-
ability of clinical pathways for adult CKD diagnosis,
management and referral. Forty-one articles were
reviewed for clinical content (i.e. screening, medical man-
agement and referral), evidence of credibility (i.e. pathway
based on guidelines), format (i.e. static/interactive, elec-
tronic/paper-based) and post-implementation evaluation.
The review identified a lack of detail and heterogeneity
related to these elements [13]. The scoping review, to-
gether with stakeholder feedback, highlighted the need to
develop a credible, evidence-based CKD clinical pathway
that could be used at the point-of-care in a primary care
setting. In this paper we describe phases 4 and 5 of
the Knowledge-To-Action Cycle, specifically how we
developed, implemented and monitored use and
feasibility of the CKD Clinical Pathway (CKD-CP)
(www.ckdpathway.ca) (Fig. 1). Phases 6 and 7 of the
Knowledge-To-Action Cycle; evaluating process and
clinical outcomes and sustaining knowledge use will
be presented in a future publication.
Methods
Study overview
Creation and implementation of the interactive point-of-
care tool (CKD-CP) for primary care providers (i.e.
physicians, pharmacists and nurses involved in the care of
patients with CKD) in Alberta, Canada was undertaken to
assist them in three aspects of CKD care: diagnosis,
management and referral.
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Development of the intervention: the CKD clinical pathway
We established a core team to develop this evidence-
based intervention, including a lead investigator, project
manager, knowledge translation specialists, information
technology lead and representatives of stakeholder groups
involved in the care of patients with CKD (i.e. primary
care physicians, pharmacists, dieticians, nurses, nephrolo-
gists and local policy makers). The role of the core team
was to oversee all aspects of the development and imple-
mentation of the CKD-CP. The core team worked closely
with external agencies (i.e. laboratory medicine, electronic
medical record vendors, primary care networks) to
facilitate development in the local context. A project plan
was created to guide all components of the project includ-
ing responsibilities, timelines, budget, service agreements
and mutual expectations. The CKD pathway development
included 3 sub-phases: (1) clinic site visits and develop-
ment of user profiles; (2) pathway design and usability
testing; and (3) pathway deployment.
Clinic site visits and development of user profiles
We undertook 8 site visits and each visit took between 45
and 60 min. Interviews were conducted with 2 nephrolo-
gists, 4 primary care physicians and 2 pharmacists to
Fig. 1 Knowledge-To-Action Cycle for the adult CKD Clinical Pathway. Adapted from Straus S, Tetroe J, Graham I. Knowledge translation in health
care: moving from evidence to practice. 2nd ed. Chichester, UK: John Wiley & Sons; 2013. p.10
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document clinical processes that would impact content,
use and uptake of a point-of-care clinical pathway for
CKD. Our previous work with focus groups identified
time constraints as a barrier to the uptake of guidelines in
clinical practice [4]. Thus, by mapping each individuals
clinical workflow (i.e. documenting their task sequence to
diagnosing, management and referral for a patient with
CKD), we were able to identify performance features of
the pathway that would facilitate its efficient integration as
a point-of-care tool in clinical practice. We determined
that both paper-based and electronic medical records
were used, sometimes in parallel to support different
tasks, although the majority of health records were
electronic. Also, clinicians reported varied levels of
computer experience and use of online clinical tools. We
identified key website features: interactive and static pages;
downloadable documents; accessibility; credibility; and
multi-layer content. These features are consistent with
those identified by Cook and colleagues to support point-
of-care resources and learning [14]. These key features
and workflow data informed the design of the CKD-CP.
Design and usability testing
Based on clinician behaviors identified at the clinic site
visits we created 4 user profiles (high-tech primary care
physician, low-tech primary care physician, pharmacist
and nurse) to capture user needs, goals, motivations,
priorities and scenarios of using an online based tool.
We contracted a design firm to create a prototype CKD-
CP. Pathway content was based on relevant published
clinical practice guidelines including the KDIGO CKD
Guidelines [2], harmonized with other relevant practice
guidelines (i.e. Canadian Cardiovascular Society, Canadian
Diabetes Association, Canadian Hypertension Education
Program and Canadian Society of Nephrology) [15–18].
Design expertise for website appearance, functionality, us-
ability and search engine optimization were provided by a
design firm. Static wireframes (visual web page schematic)
were initially created, followed by an interactive click-
through prototype. As website development is an iterative
process, and to ensure maximum usability of the clinical
pathway, we did usability testing at both the static wire-
frame and prototype phases. Usability testing as defined
by the International Organization for Standardization
(ISO) standard 9241-11 is “…the extent to which a prod-
uct can be used by specified users to achieve specified
goals with effectiveness, efficiency and satisfaction in a
specified context of use” [19]. Studies have shown that
80 % of usability issues are detected by a sample of 6 – 8
users [20]. Therefore, we conducted usability testing with
domain experts (2 nephrologists) and representatives of
the target audience (2 primary care physicians, 2 pharma-
cists and 1 nurse practitioner). Participants were first
asked a short set of demographic questions and were then
provided with 3 clinical scenarios that would mimic real
world practice, specifically screening, diagnosing,
managing and appropriate referral for CKD. Participants
worked through the scenarios using the CKD-CP proto-
type while engaging in a “think-aloud” exercise in which
the facilitator asked the subject to communicate their
thought processes verbally while they performed the task
[20]. The facilitator took written notes recording both
verbal responses and observations. Participants also
completed a System Usability Scale questionnaire to iden-
tify usability issues [21]. Descriptive statistics and thematic
coding of the think-aloud exercise were used to analyze
the data. Participants provided input regarding operating
systems, interactive website features, ‘levels of detail’ of
information and the quality of the evidence-based re-
sources. Participants also emphasized the need for rapid
diagnosis and relevant patient handouts. These perform-
ance and usability findings (categorized by importance)
were used to finalize the CKD-CP prior to deployment.
The CKD-CP website has five main sections: The Pathway
(home page) (Fig. 2), Diagnosis, Medical Management,
Referral and Resources (Additional file 1). The website has
both static information, such as patient education handouts
along with interactive features (diagnosis tool, Framingham
Risk Score) to provide users with more information. The
main features of each section are summarized in Table 1.
Deployment
The interactive CKD-CP was migrated to a free public
website to allow access to all end-users. Documentation,
application software code and technical specifications
were transferred from the design firm after the website
launch. Maintenance and governance agreements with
our server provider (provincial health authority) were
created to ensure sustainability, ongoing support and
regular updates.
Clinical Pathway dissemination and implementation
Our stakeholders remained engaged at all phases of the
Knowledge-To-Action Cycle, including dissemination
and implementation. According to Rabin et al. ([22],
p.118) “dissemination is the active approach of spreading
evidence-based interventions to the target audience
using planned strategies, whereas implementation is the
process of integrating the intervention within a setting”.
Using the Knowledge Translation Planning Template –R
™ [23] we developed a multi-faceted dissemination and
implementation approach to assist us in generating
awareness, interest and knowledge regarding the CKD-
CP and the care of patients with CKD. The strategies in-
corporated getting the right information (tailored key
messages) to the right people (target audiences) in the
right format (mode of delivery) at the right time (Fig. 3).
We engaged with many organizations (i.e. professional
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colleges, associations), networks and academic institutions
to disseminate via social media, newsletters and email. Mass
media releases were done provincially. At continuing med-
ical education events, medical trainee workshops, multi-
disciplinary conferences and small group sessions we had
attendees use the website as they worked through case stud-
ies. Through all our communications, we encouraged clini-
cians to bookmark the website for seamless access to tool.
Monitor knowledge use
We used a mixed methods approach to monitor the
CKD Clinical Pathway use and feasibility, including indi-
vidual interviews to obtain users perspectives and expe-
riences, an online survey to explore satisfaction with the
tool and website analytics to capture website usage and
user characteristics.
Individual interviews
We used a purposive sampling approach with research
team members identifying potential participants (e.g.
primary care physicians, nurses, pharmacists and ne-
phrologists) to participate in in-person or telephone
interviews. Semi-structured interviews were conducted
6 months after the website launch, by an experienced
interviewer. Interviews were continued until saturation
of themes (i.e. no new data generated) was achieved (18
participants). The interviews focused on the CKD-CPs:
(1) impact on clinical workflow; (2) usability; and (3) in-
fluence on practice behaviors. The interviews, approxi-
mately 20 min in duration, were audio-recorded and
transcribed. Conventional qualitative content analysis
was used to interpret the interview data [24]. MD, PL
and JP read entire transcripts, identified codes and
Fig. 2 CKD Clinical Pathway home page
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sorted related codes into themes. The interview results
were used to inform the content of the online survey.
Online survey
An online survey was used to explore satisfaction with the
CKD-CP in a larger group of CKD-CP users, including cli-
nicians and others (i.e. non-healthcare users). Primary care
physicians across Alberta were sent a letter of invitation
via fax using publically available fax numbers from the
College of Physicians and Surgeons of Alberta [25],
inviting them to complete the short online survey,
administered using FluidSurveys [26]. To capture feedback
from non-physician CKD-CP end-users (pharmacists,
nurses, other clinicians, non-healthcare providers) and
primary care physicians outside of Alberta, a “pop-up”
request on the publicly available CKD-CP website was
activated for a 6 week period. The pop-up request referred
respondents to the FluidSurvey link. Descriptive analysis
was used to report survey responses. The survey was
composed of 16 closed-ended questions that addressed
website usefulness, knowledge and confidence with
identifying, managing and referral of patients with CKD.
Participant demographic data was also collected.
Website analytics
We used Google Analytics, a web analytics program, to
gather data on website utilization, specifically website traffic
(number and type of visitors), traffic sources (geographic
and internet) and visitor behaviors (content interest) [27].
Descriptive statistics were used to describe these data





Eighteen interviews were conducted with 10 primary
care physicians, 3 nephrologists, 2 pharmacists and 3
nurse practitioners. There were 10 women (56 %) and 8
men (44 %) with 89 % practicing in an urban setting.
The majority of participants (56 %) had been in practice
for 11–30 years. The frequency of website use reported
by participants in the prior 6 months included 5 (28 %)
who reported access less than 5 times, 4 (22 %) between
6 and 10 times, 6 (33 %) between 11 and 20 times and 3
(17 %) who reported using it greater than 20 times.
Themes
Three major themes reflecting the barriers and facilita-
tors to integrating the CKD-CP into clinical practice
Fig. 3 Key messages, audiences and methodology for dissemination and implementation
Table 1 Description of main sections on the CKD Clinical
Pathway Website
Section Description
Home Page • Overview of interactive CKD algorithm
• List of clinical practice guidelines used to
inform the clinical pathway content
• Who and how to test for CKD
• Disclaimer
Diagnose • Interactive diagnose tool with drop down
menu for laboratory test results
• Provides CKD diagnosis and recommended
care (medical management, referral)




• Drug therapy (prescribing information,
dosage, contraindications, general information)
for ACEi/ARB, statins and antiplatelet agents
• Printable patient handouts
Referral • Referral criteria
• Referral form
Resources • Classification of CKD
• Prognosis and frequency of testing
• Framingham cardiovascular disease
risk calculator
• Management of elevated serum potassium
• Clinical practice guidelines
• Drug references
Contact • Email clinical or technical questions
Abbreviations: eGFR estimated glomerular filtration rate, ACR random urine
albumin-creatinine ratio, ACEi/ARB angiotensin converting enzyme inhibitor or
angiotensin receptor blocker
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were identified, and included: communication; work
efficiency; and confidence (Table 2). Interviewees reported
that use of the clinical pathway resulted in enhanced com-
munication within the multi-disciplinary primary care team
and between the primary care team and the specialist and/
or specialty clinic. Also, the tool was perceived to provide
opportunities to augment communication (i.e. through use
of patient handouts) between the health care providers and
their patients. Participants highlighted the need for more
patient handouts to facilitate patient self-management and
information related to CKD medications. Barriers to
communication included the inability to complete a direct
electronic referral to the nephrologist. Participants reported
that having an interactive point-of-care tool accessible by
other team members could improve work efficiency, but
also noted that there were technical issues based on
browser version and the inability of the tool to integrate
with their Electronic Medical Record. Finally, participants
viewed the CKD-CP website as a credible tool, which
provided knowledge and training that would help facilitate
behavior change in the care of patients with CKD.
Online survey
The online survey was available from June 1st to July
13th, 2015. Overall 159 participants completed the online
survey (the number of potential respondents is unknown),
of whom 141 (89 %) were healthcare providers, 9 (5.5 %)
were non-health care providers (i.e. person with kidney
disease or person who cares for someone with kidney dis-
ease) and 9 (5.5 %) were unknown. 52 (33 %) participants
reported previously using the CKD-CP, 83 (52 %) reported
this was their first use, and 24 (15 %) did not report. Of the
16 healthcare respondents with prior use who fully com-
pleted the survey, 15 (94 %) agreed or strongly agreed that
the pathway was user friendly and provided useful informa-
tion regarding CKD. The majority (n = 11; 69 %) found the
printable patient handouts useful. Overall the majority of
respondents (81 %) reported that the tool increased their
knowledge and confidence in the care (i.e. screening, diag-
nosis, management and referral) of patients with CKD.
Website analytics
The CKD-CP was launched November 5th, 2014. From
November 5th, 2014 to July 31st, 2015 there were 10,710
visits, with 7,146 new visitors (67 %) and 3,564 return
visitors (33 %) (Fig. 4). The majority of visitors were
from Canada (85 %), followed by Indonesia (6 %) and
the United States (2.4 %). Fifty percent of visitors
accessed the website by typing the URL into their
browser or by bookmarking it as a favorite. Other users
accessed it using a search engine or were referred by
other professional organization’s websites. The 5 web
pages most frequently viewed (average time spent in
minutes) included the: home page (1.17); diagnose page
(1.04); medical management page (2.33), who and how
to test page (1.23); and referral page (1.29). There were
30,323 page views with the majority of users (42 %)
starting with the home page and then moving to either
the diagnose page or medical management page. The
majority (61 %) of users leaving the diagnose page went
to the medical management page. Return users are
accessing the diagnose (4 %), medical management
(2 %), referral (0.8 %) and resources pages (0.8 %) more
often than first time users.
Discussion
Although multiple CKD clinical pathways are available,
there is significant variability in the quality, content and
evaluation of the use and impact of these tools [13]. We
used the Knowledge-To-Action Cycle to guide the devel-
opment and implementation of an online CKD-CP for
diagnosis, management and referral of adults with CKD
in primary care. Indicators used to monitor and evaluate
health information tools with regards to their effect and
use include their reach, usefulness and collaboration and
capacity building [28]. Using these metrics, our findings
suggest that the CKD-CP is feasible for use as a point-
of-care tool in the primary care setting.
In terms of reach, the CKD-CP is an unrestricted online
tool that has been accessed by individuals from a variety of
countries, including those in North America and abroad,
demonstrating geographical breadth. Previous research has
indicated that reminders, interactive small group meetings
and mass media campaigns are the most effective dissemin-
ation strategies, with unknown effects of social media and
networks [23, 29]. We will continue to do multi-faceted
dissemination activities, including a prompt (i.e. hyperlink
to the website via laboratory reports within Alberta), adver-
tising the pathway on other websites that primary care
providers’ access, podcasts and interactive small group dis-
cussions with primary care networks.
There was preliminary evidence of CKD-CP useful-
ness, as determined by end-user satisfaction and
perceived value of the pathway based on data from the
interviews and the online survey. The CKD-CP was de-
signed for use at the point-of-care, with the ability to
diagnose CKD within 3 min (a priority as identified by
our primary care stakeholders). On average website users
are able to complete a diagnosis in 1.04 min using the
diagnose page to input lab values via dropdown menus.
Our data suggests that the majority of users are proceed-
ing from the diagnose page to the medical management
page indicating that users are not leaving the website
after using the diagnose page. While the average time
spent on the referral page was 1.29 min, integration of
the CKD-CP into the electronic medical record with
auto-populating fields for diagnosis and referral could
optimize work efficiency in the future. Importantly, the
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ability to access the tool by members of the primary care
multi-disciplinary team was identified as a positive
feature as it assisted in clinic workflow processes. This is
supported by a recent systematic review which reported
improvements in diabetes care for tools that were
integrated and available at point-of-care [30]. Our results
also reveal that 33 % of users are returning to use the
tool for diagnosis, medical management, referral and
resources, which suggests that it meets their expecta-
tions and needs for caring for patients with CKD.
Some technical limitations were identified. Clinicians
using an older browser version experienced limited tool
functionality. In Canada, there has been a decrease in
use of these older browsers, with only 3 % of computer
users between November 2014 and July 2015 using
Internet Explorer 8 [31]. The tool was developed to
function on newer browsers running on both desktop
computers and tablets to enable use of novel interactive
features. Technical issues are common with complex










Facilitator “…not creating a way
that our specialist
colleagues tell us what
they think we should be
doing. But rather
how can they help us,
how can they help us
improve, recognizing








Facilitator “We have access to other
health care practitioners,
we have educators,
we have specialists that
are linked to our primary
care network. So this will
compliment that” (PCP08)
“Try to maintain continuity
with a lot of our patients
who see our residents…
good for them so the
patient knows what








good for patients to
reinforce information……
validates our plan to them
(patient)” (PCP02)
“Some sort of handout for
patients on what sort
of meds they can be on”
(PHARM01) “Part of our
problem as specialists is
we don’t clarify
or make it (CKD care) very




Facilitator “We should all get on the
same page… I love the
fact that they’ve chosen
to do eGFRs” (PCP03) “every
physician is different, but
this is one resource we
can turn to for consistency
purposes for my practice”
(N02)
Inability to do electronic
referral (eReferral) from
within tool
Barrier “eReferral – link EMR and
referral – forces you to put
the right pieces in” (PCP03)
Work efficiency
Point-of-care tool,
with single access point
Facilitator “It’s very quick to decide
if someone has CKD,
it reminds me about the
things I have to do…”
(PCP01) “Great to have
all that information in one
place” (PCP03) “Easy to
quickly run through it
when you’re in between
patients or on a visit if you
Table 2 Main themes identified from individual interviews
(Continued)




use tool which assists
with clinic workflow
Facilitator “Before I see a patient
my medical office assistant
just clicks”(PCP08)
“Chronic disease nurse
using the CKD pathway –




Barrier “It is a great resource and
it’s a shame that we
cannot access it” (N02)
Inability to link directly
to EMR
Barrier “Hoping that this CKD
pathway is to be
part of our EMR” (PCP08)
Confidence
Viewed as credible site Facilitator “Can be comfortable
saying…. from a position
of knowledge” (PCP03)
Provides knowledge
and training for CKD
Facilitator “Demonstrating CKD
information to student/




Facilitator “it (tool) encourages me
not to screen as broadly
as I was screening” (PCP04)
“comfort level did not
have before, it’s like a tool
for identifying patients”
(PCP08) “I’ve even adjusted
some of my recommen
dations based on it (tool)
to reflect
more clearly what is
in the Pathway” (NEPH01)
PCP primary care physician, N nurse, NEPH nephrologist, PHARM pharmacist
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software and their use in physician practices [32].
Important strengths of the CKD-CP are its use of
evidence-based guidelines to inform the content, as well
as its endorsement by academic institutions and
Alberta’s single health region. The original purpose of
the CKD-CP was to assist primary care providers to
diagnose, manage and appropriately refer patients with
CKD. Users have reported that the pathway provides
CKD knowledge, and can be used to train and educate
students and other team members. Website users have
also reported that the tool has increased their confi-
dence, which has led to behavior changes in terms of
screening, managing and referral of patients with CKD.
Collaborations and capacity building is reflected in the
diverse partnerships that have been created and the
sharing of information and expertise at local and
national levels, including collaborations with a design
firm, IT specialists, electronic medical record vendors,
laboratory medicine, primary care networks, other health
authorities, renal networks, professional associations,
primary care professionals and community clinics. Crisp
and colleagues state that partnerships can lead to the
two-way flow of knowledge which is needed to plan and
implement a health program and build capacity [33]. We
will continue information sharing and exchange of
expertise with other networks and organizations within
Canada. We are promoting evidence-based care for
patients with CKD through our dissemination and
implementation strategies at the local, national and
international levels including activities such as joint
presentations (with other jurisdictions), international
conferences and open access to the tool.
Our use of a mixed methods methodology allowed us
to obtain data on the usability and feasibility of the
CKD-CP; however the results should be interpreted in
light of study limitations. First, the number of respon-
dents to the survey compared to the number of visitors
to the site was very small, and may have resulted in a
response bias. Second, selection bias may also be an
issue for both interviews and the online survey. The
majority of participants interviewed had urban-based
practices and their responses may not reflect those of
rural primary care providers. Third, our evaluation at
this stage is primarily descriptive and ecological in
nature. Finally, our presented work does not quantify
clinician and system behavior change or clinical and
process outcomes per se, but does highlight website
awareness, interest and current use of knowledge related
to CKD. These findings are important for making refine-
ments to the CKD –CP website via ongoing discussions
with clinicians and the development team. Stages 5 and
6 of the Knowledge-To-Action Cycle; evaluating process
and clinical outcomes and sustaining knowledge use will
be the focus of a forthcoming publication.
Conclusions
Using the Knowledge-To-Action Cycle as a framework,
we report the development and implementation of an
online adult CKD-CP. Our findings highlight the import-
ance of assessment of end-users awareness, satisfaction
with the content, accessibility and perceived quality of
the pathway. The CKD-CP was designed to address the
evidence to practice gap in the care of patients with
CKD identified in our previous work: time limitations;
knowledge; and communication with specialists. Our find-
ings have identified future end-user and stakeholder needs
to ensure sustainability, including continual dissemination,
additional patient materials, electronic referral capabilities
and integration into electronic medical records.
Fig. 4 New versus returning visitors, by month since implementation
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Additional file
Additional file 1: A) Diagnose page B) Medical Management page
C) Referral page D) Resources page. (PDF 15822 kb)
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